Mers-cov membrane protein receptor binding domain dimer and its encoding gene and application
A dimer and protein technology, applied in the fields of application, genetic engineering, plant genetic improvement, etc., can solve the problem of uncertain source and host, and achieve the effect of good immunogenicity and extensive theoretical guidance value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Example 1. Preparation of MERS-CoV RBD monomer and MERS-CoV RBD dimer
[0055] 1. Construction of recombinant plasmids
[0056] Replace pFastBac with the double-stranded DNA molecule shown in SEQ ID NO: 6 of the Sequence Listing TM A small fragment between the BglII and SalI restriction sites of the dual vector was obtained to obtain the recombinant plasmid A. In Sequence 6 of the sequence listing, the 1-114 nucleotides encode the gp67 signal peptide, the 124-792 nucleotides encode the RBD monomer, and the 793-810 nucleotides encode His 6 Label. The DNA molecule shown in SEQ ID NO: 6 of the Sequence Listing encodes the protein shown in SEQ ID NO: 5 of the Sequence Listing. The gp67 signal peptide is cleaved during the process of insect cell expression and secretion to form a mature protein consisting of amino acid residues 39-270 in SEQ ID NO: 5 of the sequence listing.
[0057]Insert the double-stranded DNA molecule shown in Sequence 8 of the Sequence Listing into...
Embodiment 2
[0090] Example 2. Antigenicity analysis (ELISA test)
[0091] Test antibody: MERS-4 or MERS-27 or 10E8. MERS-4 is the monoclonal antibody MERS-4, and the preparation method is described in the patent "Monoclonal Antibody MERS-4 and Its Encoding Gene and Application" (Application No. 201310566227.8; Authorized Announcement No. CN104628849B). MERS-27 is the monoclonal antibody MERS-27, and the preparation method is described in the patent "Monoclonal Antibody MERS-27 and Its Encoding Gene and Application" (Application No. 201310565893.X; Authorized Announcement No. CN104628848B). Both MERS-4 and MERS-27 are neutralizing antibodies against MERS-CoV RBD. 10E8 is a monoclonal antibody against HIV-1 membrane protein (used as a negative reference).
[0092] Antigen solution: MERS-CoV RBD monomer solution or MERS-CoV RBD dimer solution prepared in Example 1. Blocking solution: PBS buffer containing 1% (v / v) fetal bovine serum. Test antibody solution: Take the test antibody and dil...
Embodiment 3
[0102] Example 3, structural analysis
[0103] The MERS-CoV RBD monomer solution and the MERS-CoV RBD dimer solution prepared in Example 1 were taken respectively, concentrated to 10 mg / ml with a 10 kD ultrafiltration tube, and the crystals were screened by the sitting drop method.
[0104] Spindle-shaped single crystals were grown under the condition of 25% PEG1500.
[0105] Diffraction data collection was performed using a synchrotron X-ray light source.
[0106] Use HKL-2000, DPP4, Coot, phoenix and other software to process the data, use the molecular replacement method to solve the phase, and finally analyze the structure.
[0107] see the results Figure 4 . Figure 4 A is the structure of MERS-CoV RBD monomer, Figure 4 The B is the structure of the MERS-CoV RBDdimer. The MERS-CoV RBD monomer contains 8 cysteines (Cys) and forms 4 pairs of intramolecular disulfide bonds. One monomer of MERS-CoV RBD dimer contains 9 Cys, of which 8 Cys will form 4 pairs of intramol...
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com